A novel monoclonal antibody effective against lethal challenge with swine-lineage and 2009 pandemic H1N1 influenza viruses in mice

Virology

Volumn 417, Issue 2, 2011, Pages 379-384

  Shao, Hongxia ^a,b   Ye, Jianqiang ^b   Vincent, Amy L ^c   Edworthy, Nicole ^b   Ferrero, Andrea ^b   Qin, Aijian ^a   Perez, Daniel R ^b  

^a YANGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND   (United States)

^c NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

H1N1pdm; Influenza; Monoclonal antibody; Protection; Swine; Treatment

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY S OIV 3B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG SPECIFICITY; FEMALE; HEMAGGLUTINATION INHIBITION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SWINE INFLUENZA VIRUS; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; RODENT DISEASES; SURVIVAL ANALYSIS;

MUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 80051924933     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.06.021     Document Type: Article

References (39)

1. Berhane Y., Ojkic D., Neufeld J., Leith M., Hisanaga T., Kehler H., Ferencz A., Wojcinski H., Cottam-Birt C., Suderman M., Handel K., Alexandersen S., Pasick J. Molecular characterization of pandemic H1N1 influenza viruses isolated from turkeys and pathogenicity of a human pH1N1 isolate in turkeys. Avian Dis. 2010, 54:1275-1285.
2. Cram P., Blitz S.G., Monto A., Fendrick A.M. Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies. PharmacoEconomics 2001, 19:223-230.
3. de Jong M.D., Bach V.C., Phan T.Q., Vo M.H., Tran T.T., Nguyen B.H., Beld M., Le T.P., Truong H.K., Nguyen V.V., Tran T.H., Do Q.H., Farrar J. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 2005, 352:686-691.
4. Donaldson L.J., Rutter P.D., Ellis B.M., Greaves F.E., Mytton O.T., Pebody R.G., Yardley I.E. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009, 339:b5213.
5. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
6. Gillissen A., Hoffken G. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med. Microbiol. Immunol. 2002, 191:165-168.
7. Hanson B.J., Boon A.C., Lim A.P., Webb A., Ooi E.E., Webby R.J. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir. Res. 2006, 7:126.
8. Howden K.J., Brockhoff E.J., Caya F.D., McLeod L.J., Lavoie M., Ing J.D., Bystrom J.M., Alexandersen S., Pasick J.M., Berhane Y., Morrison M.E., Keenliside J.M., Laurendeau S., Rohonczy E.B. An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm. Can. Vet. J. 2009, 50:1153-1161.
9. Hu J., Robinson J.L. Treatment of respiratory syncytial virus with palivizumab: a systematic review. World J. Pediatr. 2010, 6:296-300.
10. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., Sugerman D.E., Druckenmiller J.K., Ritger K.A., Chugh R., Jasuja S., Deutscher M., Chen S., Walker J.D., Duchin J.S., Lett S., Soliva S., Wells E.V., Swerdlow D., Uyeki T.M., Fiore A.E., Olsen S.J., Fry A.M., Bridges C.B., Finelli L. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 2009, 361:1935-1944.
11. Kashyap A.K., Steel J., Rubrum A., Estelles A., Briante R., Ilyushina N.A., Xu L., Swale R.E., Faynboym A.M., Foreman P.K., Horowitz M., Horowitz L., Webby R., Palese P., Lerner R.A., Bhatt R.R. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog. 2010, 6:e1000990.
12. Lamb R.A. Genes and proteins of the influenza viruses. The Influenza Viruses 1989, Plenum Press, New York. 1st ed. R.M. Krug (Ed.).
13. Le Q.M., Kiso M., Someya K., Sakai Y.T., Nguyen T.H., Nguyen K.H., Pham N.D., Ngyen H.H., Yamada S., Muramoto Y., Horimoto T., Takada A., Goto H., Suzuki T., Suzuki Y., Kawaoka Y. Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005, 437:1108.
14. Libster R., Bugna J., Coviello S., Hijano D.R., Dunaiewsky M., Reynoso N., Cavalieri M.L., Guglielmo M.C., Areso M.S., Gilligan T., Santucho F., Cabral G., Gregorio G.L., Moreno R., Lutz M.I., Panigasi A.L., Saligari L., Caballero M.T., Egues Almeida R.M., Gutierrez Meyer M.E., Neder M.D., Davenport M.C., Del Valle M.P., Santidrian V.S., Mosca G., Garcia Dominguez M., Alvarez L., Landa P., Pota A., Bolonati N., Dalamon R., Sanchez Mercol V.I., Espinoza M., Peuchot J.C., Karolinski A., Bruno M., Borsa A., Ferrero F., Bonina A., Ramonet M., Albano L.C., Luedicke N., Alterman E., Savy V., Baumeister E., Chappell J.D., Edwards K.M., Melendi G.A., Polack F.P. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N. Engl. J. Med. 2010, 362:45-55.
15. Louie J.K., Acosta M., Jamieson D.J., Honein M.A. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Engl. J. Med. 2010, 362:27-35.
16. Ma W., Vincent A.L., Lager K.M., Janke B.H., Henry S.C., Rowland R.R., Hesse R.A., Richt J.A. Identification and characterization of a highly virulent triple reassortant H1N1 swine influenza virus in the United States. Virus Genes 2010, 40:28-36.
17. Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., Gustin K.M., Pearce M.B., Viswanathan K., Shriver Z.H., Raman R., Cox N.J., Sasisekharan R., Katz J.M., Tumpey T.M. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009, 325:484-487.
18. Pereda A., Cappuccio J., Quiroga M.A., Baumeister E., Insarralde L., Ibar M., Sanguinetti R., Cannilla M.L., Franzese D., Escobar Cabrera O.E., Craig M.I., Rimondi A., Machuca M., Debenedetti R.T., Zenobi C., Barral L., Balzano R., Capalbo S., Risso A., Perfumo C.J. Pandemic (H1N1) 2009 outbreak on pig farm, Argentina. Emerg. Infect. Dis. 2010, 16:304-307.
19. Prabhu N., Prabakaran M., Hongliang Q., He F., Ho H.T., Qiang J., Goutama M., Lim A.P., Hanson B.J., Kwang J. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza. Antivir. Ther. 2009, 14:911-921.
20. Reece P.A. Neuraminidase inhibitor resistance in influenza viruses. J. Med. Virol. 2007, 79:1577-1586.
21. Reed L.J., Muench H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
22. Shinde V., Bridges C.B., Uyeki T.M., Shu B., Balish A., Xu X., Lindstrom S., Gubareva L.V., Deyde V., Garten R.J., Harris M., Gerber S., Vagasky S., Smith F., Pascoe N., Martin K., Dufficy D., Ritger K., Conover C., Quinlisk P., Klimov A., Bresee J.S., Finelli L. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N. Engl. J. Med. 2009, 360:2616-2625.
23. Simmons C.P., Bernasconi N.L., Suguitan A.L., Mills K., Ward J.M., Chau N.V., Hien T.T., Sallusto F., Ha do Q., Farrar J., de Jong M.D., Lanzavecchia A., Subbarao K. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 2007, 4:e178.
24. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S., Guan Y., Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459:1122-1125.
25. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
26. Throsby M., van den Brink E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., Bakker A., Cox F., van Deventer E., Guan Y., Cinatl J., ter Meulen J., Lasters I., Carsetti R., Peiris M., de Kruif J., Goudsmit J. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 2008, 3:e3942.
27. Vijaykrishna D., Poon L.L., Zhu H.C., Ma S.K., Li O.T., Cheung C.L., Smith G.J., Peiris J.S., Guan Y. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010, 328:1529.
28. Vincent A.L., Ma W., Lager K.M., Gramer M.R., Richt J.A., Janke B.H. Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 2009, 39:176-185.
29. Vincent A.L., Swenson S.L., Lager K.M., Gauger P.C., Loiacono C., Zhang Y. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Vet. Microbiol. 2009, 137:51-59.
30. Vincent A.L., Lager K.M., Faaberg K.S., Harland M., Zanella E.L., Ciacci-Zanella J.R., Kehrli M.E., Janke B.H., Klimov A. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respi. Viruses 2010, 4:53-60.
31. Webster R.G. Predictions for future human influenza pandemics. J. Infect. Dis. 1997, 176:S14-S19.
32. Webster R.G., Shortridge K.F., Kawaoka Y. Influenza: interspecies transmission and emergence of new pandemics. FEMS Immunol. Med. Microbiol. 1997, 18:275-279.
33. Webster R., Cox N., Stohr K. WHO manual on animal influenza diagnosis and surveillance. World Health Organization Department of Communicable Disease Surveillance and Response 2005.
34. Weingartl H.M. Did the 2009 pandemic influenza virus originate in humans?. Futur. Microbiol. 2010, 5:989-991.
35. Weingartl H.M., Berhane Y., Hisanaga T., Neufeld J., Kehler H., Emburry-Hyatt C., Hooper-McGreevy K., Kasloff S., Dalman B., Bystrom J., Alexandersen S., Li Y., Pasick J. Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd. J. Virol. 2010, 84:2245-2256.
36. Wrammert J., Koutsonanos D., Li G.M., Edupuganti S., Sui J., Morrissey M., McCausland M., Skountzou I., Hornig M., Lipkin W.I., Mehta A., Razavi B., Del Rio C., Zheng N.Y., Lee J.H., Huang M., Ali Z., Kaur K., Andrews S., Amara R.R., Wang Y., Das S.R., O'Donnell C.D., Yewdell J.W., Subbarao K., Marasco W.A., Mulligan M.J., Compans R., Ahmed R., Wilson P.C. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208:181-193.
37. Yang M., Berhane Y., Salo T., Li M., Hole K., Clavijo A. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein. J. Virol. Methods 2008, 147:265-274.
38. Ye J., Shao H., Hickman D., Angel M., Xu K., Cai Y., Song H., Fouchier R.A., Qin A., Perez D.R. Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice. Clin. Vaccine Immunol. 2010, 17:1363-1370.
39. Ye J., Sorrell E.M., Cai Y., Shao H., Xu K., Pena L., Hickman D., Song H., Angel M., Medina R.A., Manicassamy B., Garcia-Sastre A., Perez D.R. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?. PLoS Pathog. 2010, 6:e1001145.